1 | A.C.A | TABLET | Acetaminophen 250mg+caffeine 65mg+ASA 250mg | ORAL | N02BE51 | AXAR | OTC medicines | |||
3 | Acetaminophen | SOLUTION | 100 mg/ml | ORAL | N02BE01 | PARACETAMOL | OTC medicines | |||
4 | Acetaminophen | SOLUTION | 120 mg/5ml 60 ml | ORAL | N02BE01 | PARACETAMOL | OTC medicines | |||
5 | Acetaminophen | SUSPENSION | 120 mg/5ml 60 ml | ORAL | N02BE01 | PARACETAMOL | OTC medicines | |||
6 | Acetaminophen | SUPPOSITORY | 125 mg | RECTAL | N02BE01 | PARACETAMOL | OTC medicines | |||
7 | Acetaminophen | TABLET | 325 mg | ORAL | N02BE01 | PARACETAMOL | OTC medicines | |||
8 | Acetaminophen | SUPPOSITORY | 325 mg | RECTAL | N02BE01 | PARACETAMOL | OTC medicines | |||
2012 | Acetaminophen | TABLET | 500 mg | ORAL | N02BE01 | PARACETAMOL | OTC medicines | |||
18420 | Acetaminophen | INJECTION, SOLUTION | 10 mg/ml | INTRAVENOUS | N02BE01 | APOTEL | Hospital use only | |||
8979 | Acetaminophen+Caffeine+Ibuprofen | CAPSULE | Acetaminophen 325mg + Caffeine 40 mg+ Ibuprofen 200mg | ORAL | N02BE71 | NOVAFEN, RIFEN | OTC medicines | |||
2243 | Acetaminophen+Codeine | TABLET | Acetaminophen 300mg + Codeine Phosphate 20mg | ORAL | N02BE71 | |||||
11 | Acetazolamide | TABLET | 250 mg | ORAL | S01EC01 | |||||
51914 | Acetylcysteine | INJECTION | 200 mg/ml | PARENTERAL | V03AB23 | NAC | Hospital use only | |||
2369 | Acetylcysteine | TABLET, EFFERVESCENT | 600 mg | ORAL | R05CB01 | NAC | ||||
23 | Aciclovir | TABLET | 400 mg | ORAL | J05AB01 | |||||
24 | Aciclovir | CREAM | 0.05 | TOPICAL | D06BB03 | |||||
2366 | Aciclovir | INJECTION, POWDER | 500 mg | PARENTERAL | J05AB01 | Hospital use only | ||||
22 | Aciclovir | INJECTION, POWDER, LYOPHILIZED | 250 mg | PARENTERAL | J05AB01 | Hospital use only | ||||
1836 | Adenosine | INJECTION | 3 mg/ml | PARENTERAL | C01EB10 | Hospital use only | HIGH ALERT | |||
5951 | Adult Cold Preparations_4: (Decongestant +Antihistamine+ Analgesic) | TABLET | As Analgesic: Acetaminophen (325, 500, 650 mg) ,As Decongestant: Phenylephrine HCl (5,10 mg) or Pseudoephedrine (30,60mg) , As Antihistamine: Diphenhydramine HCl (12.5, 25 mg) or Chlorpheniramine maleate (2 , 4 mg) or Clemastine fumarate (0.335mg) | ORAL | R05X | CORIZAN | OTC medicines | |||
27 | Albumin (Human) | INJECTION, SOLUTION | 20%, 100ml | PARENTERAL | B05AA01 | Hospital use only | ||||
38 | Allopurinol | TABLET | 100 mg | ORAL | M04AA01 | |||||
2017 | Allopurinol | TABLET | 300 mg | ORAL | M04AA01 | |||||
40 | Alprazolam | TABLET | 0.5 mg | ORAL | N05BA12 | XANAX | ||||
1382 | Alprazolam | TABLET | 1 mg | ORAL | N05BA12 | XANAX | ||||
5775 | Alteplase | INJECTION, POWDER | 50 mg | PARENTERAL | B01AD02 | ACTILYSE | Acute Ischemic Strock Acute Myocardial Infarction Pulmonary Embolism | Hospital use only | HIGH ALERT | |
49 | Aluminium/Magnesium/Simethicone | SUSPENSION | (Aluminium hydroxide 225mg+magnesium hydroxide 200mg+simethicone 25mg)/5ml | ORAL | A02AF02 | OTC medicines | ||||
51 | Amantadine | HCl | CAPSULE | 100 mg | ORAL | N04BB01 | VIRALESS, AMMOREL | |||
53 | Amikacin | As Sulfate | INJECTION | 50 mg/ml, 2ml | PARENTERAL | J01GB06 | Hospital use only | LOOK ALIKE | ||
54 | Amikacin | As Sulfate | INJECTION | 250 mg/ml, 2ml | PARENTERAL | J01GB06 | Treatment of bronchopulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients | Hospital use only | ||
56 | Aminoacid | INJECTION, SOLUTION | 0.1 (Total weight of Amino Acids equal to 100g/l) | INTRAVENOUS DRIP | B05BA01 | Hospital use only | HIGH ALERT | |||
57 | Aminoacid | INJECTION, SOLUTION | 0.05 (Total weight of Amino Acids equal to 50g/l) | INTRAVENOUS DRIP | B05BA01 | Hospital use only | HIGH ALERT | |||
56 | Aminoacid | INJECTION, SOLUTION, CONCENTRATE | 10%, 250ml (Total weight of Amino Acids equal to 100g/l) | INTRAVENOUS DRIP | B05BA01 | Hospital use only | HIGH ALERT | |||
61 | Aminophylline | INJECTION | 25 mg/ml | PARENTERAL | R03DA05 | Hospital use only | ||||
63 | Amiodarone | HCl | TABLET | 200 mg | ORAL | C01BD01 | ||||
64 | Amiodarone | HCl | INJECTION | 50 mg/ml, 3ml | PARENTERAL | C01BD01 | For the acute treatment and prophylaxis of life-threatening ventricular tachycardia or ventricular fibrillation. | Hospital use only | HIGH ALERT | |
65 | Amitriptyline | HCl | TABLET | 10 mg | ORAL | N06AA09 | ||||
68 | Amitriptyline | HCl | TABLET | 25 mg | ORAL | N06AA09 | ||||
70 | Amlodipine | As Besilate | TABLET | 5 mg | ORAL | C08CA01 | ||||
70 | Amlodipine | As Besilate | TABLET | 5 mg | ORAL | C08CA01 | ||||
77 | Amoxicillin | CAPSULE | 500 mg | ORAL | J01CA04 | |||||
78 | Amoxicillin | POWDER, FOR SUSPENSION | 250 mg/5ml | ORAL | J01CA04 | |||||
80 | Ampicillin | As Sodium | INJECTION, POWDER | 1 g | PARENTERAL | J01CA01 | ||||
81 | Ampicillin | As Sodium | INJECTION, POWDER | 250 mg | PARENTERAL | J01CA01 | ||||
82 | Ampicillin | As Sodium | INJECTION, POWDER | 500 mg | PARENTERAL | J01CA01 | ||||
84 | Ampicillin | CAPSULE | 250 mg | ORAL | J01CA01 | |||||
85 | Ampicillin | CAPSULE | 500 mg | ORAL | J01CA01 | |||||
6938 | Ampicillin+Sulbactam | INJECTION, POWDER | 3 g (2 g Ampicillin +1 g Sulbactam) | PARENTERAL | J01CR01 | AMPISUL | Hospital use only | |||
6939 | Ampicillin+Sulbactam | INJECTION, POWDER | 1.5 g (1 g Ampicillin + 0.5 g Sulbactam) | PARENTERAL | J01CR01 | AMPISUL | Hospital use only | |||
52345 | Anti-D Immunoglobulin | INJECTION | 300 mcg | PARENTERAL | J06BB01 | ROGAM | Hospital use only | |||
96 | Antihemorrhoid | OINTMENT | (Lidocaine 50mg+hydrocortisone acetate 2.75mg+aluminium subacetate 35mg+zinc oxide 180mg)/g | RECTAL | N01BB52 | OTC medicines | ||||
97 | Antihemorrhoid | SUPPOSITORY | Lidocaine 60mg+hydrocortisone acetate 5mg+aluminium subacetate 50mg+zinc oxide 400mg | RECTAL | N01BB52 | OTC medicines | ||||
51891 | Artificial tears | DROPS, SOLUTION | 0.3 % 10 mL | OPHTHALMIC | TEARLOSE | |||||
106 | ASA (Acetylsalicylic Acid) | TABLET, CHEWABLE | 100 mg | ORAL | N02BA01 | |||||
107 | ASA (Acetylsalicylic Acid) | TABLET | 325 mg | ORAL | N02BA01 | OTC medicines | ||||
1395 | ASA (Acetylsalicylic Acid) | TABLET, DELAYED RELEASE | 80 mg | ORAL | B01AC06 | OTC medicines | ||||
144 | Atenolol | TABLET | 100 mg | ORAL | C07AB03 | |||||
1910 | Atorvastatin | As Calcium | TABLET | 10 mg | ORAL | C10AA05 | ||||
1911 | Atorvastatin | As Calcium | TABLET | 20 mg | ORAL | C10AA05 | ||||
1912 | Atorvastatin | As Calcium | TABLET | 40 mg | ORAL | C10AA05 | ||||
117 | Atracurium | Besylate | INJECTION | 10 mg/ml, 5ml | PARENTERAL | M03AC04 | Hospital use only | HIGH ALERT | ||
119 | Atropine | Sulfate | INJECTION | 0.5 mg/ml | PARENTERAL | A03BA01 | Hospital use only | HIGH ALERT VITAL | ||
123 | Azithromycin | CAPSULE | 250 mg | ORAL | J01FA10 | |||||
2373 | Azithromycin | POWDER, FOR SUSPENSION | 200 mg/5ml, 30 ml | ORAL | J01FA10 | |||||
2373 | Azithromycin | POWDER, FOR SUSPENSION | 100 mg/5ml, 30 ml | ORAL | J01FA10 | |||||
2407 | Azithromycin | TABLET | 500 mg | ORAL | J01FA10 | |||||
130 | Baclofen | TABLET | 25 mg | ORAL | M03BX01 | |||||
130 | Baclofen | TABLET | 25 mg | ORAL | M03BX01 | |||||
129 | Baclofen | TABLET | 10 mg | ORAL | M03BX01 | |||||
2372 | Beractant | INJECTION, SUSPENSION | 25 mg/ ml, 8ml | INTRATRACHEAL | R07AA | BERAKSURF, SURVANTA | Treatment of full-term newborn infants with respiratory failure caused by meconium aspiration syndrome, persistent pulmonary hypertension of the newborn, or pneumonia and sepsis. (Survanta) | Hospital use only | ||
148 | Betahistine | Dihydrochloride | TABLET | 8 mg | ORAL | N07CA01 | BETASERC, ACTOSERC | |||
149 | Betamethasone | As Disodium Phosphate | INJECTION | 4 mg/ml | PARENTERAL | H02AB01 | ||||
150 | Betamethasone | TABLET | 0.5 mg | ORAL | H02AB01 | |||||
153 | Betamethasone | INJECTION, SUSPENSION, EXTENDED RELEASE | (Betamethasone acetate 3mg+Betamethasone(as disodium phosphate) 3mg)/ml | PARENTERAL | H02AB01 | |||||
160 | Betamethasone | As Valerate | OINTMENT | 0.1% | TOPICAL | D07AC01 | ||||
162 | Bethanechol | Chloride | TABLET | 10 mg | ORAL | N07AB02 | ||||
164 | Biperiden | HCl | TABLET | 2 mg | ORAL | N04AA02 | ||||
165 | Biperiden | Lactate | INJECTION | 5 mg/ml | PARENTERAL | N04AA02 | ||||
166 | Bisacodyl | SUPPOSITORY | 10 mg | RECTAL | A06AB02 | OTC medicines | ||||
167 | Bisacodyl | TABLET, DELAYED RELEASE | 5 mg | ORAL | A06AB02 | OTC medicines | ||||
168 | Bisacodyl | SUPPOSITORY | 5 mg | RECTAL | A06AB02 | OTC medicines | ||||
169 | Bismuth | Subcitrate | TABLET | 120 mg | ORAL | A02BX05 | OTC medicines | |||
11472 | Bisoprolol | Fumarate | TABLET | 2.5 mg | ORAL | C07AB07 | CONCOR, BETALCO | Hypertension, Angina | ||
7125 | Bisoprolol | Fumarate | TABLET | 5 mg | ORAL | C07AB07 | CONCOR, BETALCO | Hypertension, Angina | ||
8904 | Bisoprolol | Fumarate | TABLET | 10 mg | ORAL | C07AB07 | Hypertension, Angina | |||
21266 | Bovine Lung Surfactant | INJECTION, POWDER, LYOPHILIZED | 120 mg | INTRATRACHEAL | R07AA | BLES | ||||
176 | Bromhexine | HCl | INJECTION | 2 mg/ml | PARENTERAL | R05CB02 | ||||
177 | Bromhexine | HCl | ELIXIR | 4 mg/5ml | ORAL | R05CB02 | OTC medicines | |||
178 | Bromhexine | HCl | TABLET | 8 mg | ORAL | R05CB02 | OTC medicines | |||
179 | Bromocriptine | As Mesylate | TABLET | 2.5 mg | ORAL | G02CB01 | ||||
8889 | Budesonide | NEBULISATION | 0.25 mg/ml, 2 ml | RESPIRATORY | R03BA02 | PULMICORT | ||||
52306 | Budesonide | NEBULISATION | 0.5 mg/ml, 2 ml | RESPIRATORY | R03BA02 | PULMICORT | ||||
1413 | Bupivacaine | HCl | INJECTION | 0.5%, 4ml | INTRASPINAL | N01BB01 | MARCAEIN | Hospital use only | ||
183 | Burn Ointment | OINTMENT | Cod liver oil 50%+Zinc oxide 30% | TOPICAL | D03AA | OTC medicines | ||||
1888 | Buspirone | HCl | TABLET | 5 mg | ORAL | N05BE01 | ||||
14000 | Caffeine | As Citrate | INJECTION, SOLUTION | 10mg/ml, 3ml | PARENTERAL | N06BC01 | hospital use only | |||
190 | Calamine | CREAM | 8% | TOPICAL | D02AB | OTC medicines | ||||
195 | Calcitriol | CAPSULE LIQUID FILLED | 0.25 mcg | ORAL | A11CC04 | ZAVITROL | ||||
50253 | Calcium | Carbonate | TABET | 500 mg | ORAL | A12AA04 | ||||
Calcium +Vitamin D | As Carbonate | TABLET | 500mg | ORAL | ||||||
200 | Calcium Gluconate | INJECTION | 10% | PARENTERAL | A12AA03 | HIGH ALERT* VITAL | ||||
Calendula | OINTMENT | 15 g | TOPICAL | |||||||
205 | Captopril | TABLET | 25 mg | ORAL | C09AA01 | |||||
206 | Captopril | TABLET | 50 mg | ORAL | C09AA01 | |||||
208 | Carbamazepine | SUSPENSION | 100 mg/5ml | ORAL | N03AF01 | TEGRETOL, TEGATARD | ||||
2475 | Carvedilol | TABLET | 6.25 mg | ORAL | C07AG02 | |||||
1924 | Carvedilol | TABLET | 12.5 mg | ORAL | C07AG02 | |||||
6757 | Caspofungin | As Acetate | INJECTION, POWDER | 50 mg | PARENTERAL | J02AX04 | Hospital use only | |||
245 | Cefalexin | CAPSULE | 500 mg | ORAL | J01DB01 | |||||
246 | Cefalexin | CAPSULE | 250 mg | ORAL | J01DB01 | |||||
222 | Cefazolin | As Sodium | INJECTION, POWDER | 1 g | PARENTERAL | |||||
224 | Cefazolin | As Sodium | INJECTION, POWDER | 500 mg | PARENTERAL | J01DB04 | ||||
2416 | Cefepime | As HCl or DiHCl | INJECTION, POWDER | 1 g | PARENTERAL | J01DE01 | Hospital use only | |||
2147 | Cefepime | As HCl or DiHCl | INJECTION, POWDER | 2 g | PARENTERAL | J01DE01 | Hospital use only | |||
226 | Cefixime | TABLET | 200 mg | ORAL | J01DD08 | |||||
227 | Cefixime | TABLET | 400 mg | ORAL | J01DD08 | |||||
229 | Cefotaxime | As Sodium | INJECTION, POWDER | 500 mg | PARENTERAL | J01DD01 | Hospital use only | |||
1336 | Cefotaxime | As Sodium | INJECTION, POWDER | 1 g | PARENTERAL | J01DD01 | Hospital use only | |||
230 | Ceftazidime | As Pentahydrate | INJECTION, POWDER | 1 g | PARENTERAL | J01DD02 | Hospital use only | |||
231 | Ceftazidime | As Pentahydrate | INJECTION, POWDER | 2 g | PARENTERAL | J01DD02 | Hospital use only | |||
233 | Ceftizoxime | As Sodium | INJECTION, POWDER | 1 g | PARENTERAL | J01DD07 | Hospital use only | |||
237 | Ceftriaxone | As Sodium | INJECTION, POWDER | 1 g | PARENTERAL | J01DD04 | HIGH ALERT | |||
239 | Ceftriaxone | As Sodium | INJECTION, POWDER | 500 mg | PARENTERAL | J01DD04 | HIGH ALERT | |||
1913 | Celecoxib | CAPSULE | 100 mg | ORAL | M01AH01 | |||||
1424 | Cetirizine | HCl | TABLET | 10 mg | ORAL | R06AE07 | OTC medicines | |||
2231 | Cetirizine | HCl | TABLET | 5 mg | ORAL | R06AE07 | LETIZEN | OTC medicines | ||
2232 | Cetirizine | HCl | SYRUP | 5mg/5ml | ORAL | R06AE07 | LETIZEN | OTC medicines | ||
Charcoal Activated | POWDER, FOR SUSPENSION | 100 g | ORAL | A07BA01 | OTC medicines | |||||
267 | Chlordiazepoxide | TABLET | 10 mg | ORAL | N05BA02 | LIBRIUM | ||||
268 | Chlordiazepoxide | TABLET | 5 mg | ORAL | N05BA02 | LIBRIUM | ||||
275 | Chlorpheniramine | Maleate | INJECTION | 10 mg/ml | PARENTERAL | R06AB04 | ||||
277 | Chlorpromazine | HCl | INJECTION | 25 mg/ml, 2ml | INTRAMUSCULAR | N05AA01 | NORMAZINE | |||
278 | Chlorpromazine | HCl | TABLET | 100 mg | ORAL | N05AA01 | NORMAZINE | |||
279 | Chlorpromazine | HCl | TABLET | 25 mg | ORAL | N05AA01 | NORMAZINE | |||
295 | Ciprofloxacin | As HCl | TABLET | 250 mg | ORAL | J01MA02 | ||||
296 | Ciprofloxacin | As HCl | TABLET | 500 mg | ORAL | J01MA02 | ||||
297 | Ciprofloxacin | As HCl | SOLUTION/ DROPS | 0.3% | OPHTHALMIC | S01AE03 | ||||
2250 | Ciprofloxacin | As Lacate | INJECTION, SOLUTION | 10 mg/ml, 20ml | INTRAVENOUS | J01MA02 | ||||
2109 | Cisatracurium | As Besylate | INJECTION | 2 mg/ml, 5ml | PARENTERAL | M03AC11 | Hospital use only | |||
1905 | Citalopram | As HBr | TABLET | 20 mg | ORAL | N06AB04 | HIGH ALERT | |||
303 | Citicoline | As Sodium | INJECTION | 125 mg/ml, 2ml | PARENTERAL | N06BX06 | Hospital use only | LOOK ALIKE | ||
187 | C-LAX | TABLET | Cassia senna leaf and extract 550 mg + Foeniculum vulgare oil 3 mg | ORAL | ||||||
308 | Clidinium+Chlordiazepoxide | bromide | TABLET | Clidinium 2.5mg + Chlordiazepoxide 5mg | ORAL | A03CA02 | LIBRAKIM | |||
309 | Clindamycin | As HCl | CAPSULE | 150 mg | ORAL | J01FF01 | LOOK ALIKE | |||
1947 | Clindamycin | As HCl | CAPSULE | 300 mg | ORAL | J01FF01 | ||||
312 | Clobazam | TABLET | 10 mg | ORAL | N05BA09 | |||||
313 | Clobetasol | Propionate | CREAM | 0.05% | TOPICAL | D07AD01 | ||||
322 | Clonazepam | TABLET | 1 mg | ORAL | N03AE01 | |||||
323 | Clonazepam | TABLET | 2 mg | ORAL | N03AE01 | |||||
324 | Clonidine | HCl | TABLET | 0.2 mg | ORAL | C02AC01 | ||||
1788 | Clopidogrel | as Bisulfate | TABLET | 75 mg | ORAL | B01AC04 | ||||
326 | Clotrimazole | CREAM | 1% | TOPICAL | D01AC01 | |||||
328 | Clotrimazole | SUPPOSITORY | 100 mg | VAGINAL | G01AF02 | OTC medicines | ||||
331 | Cloxacillin | As Sodium | CAPSULE | 500 mg | ORAL | J01CF02 | ||||
332 | Cloxacillin | As Sodium | INJECTION, POWDER | 500 mg | PARENTERAL | J01CF02 | ||||
1743 | Clozapine | TABLET | 25 mg | ORAL | N05AH02 | |||||
337 | Co-amoxiclav | TABLET | 375 mg (Amoxicillin(as trihydrate) 250mg+Clavulanic acid(as potassium) 125mg) | ORAL | J01CR02 | |||||
1440 | Co-amoxiclav | POWDER, FOR SUSPENSION | 312: (Amoxicillin(as trihydrate) 125mg+Clavulanic acid(as potassium) 31.25mg)/5ml | ORAL | J01CR02 | |||||
348 | Colchicine | TABLET | 1 mg | ORAL | M04AC01 | Treatment of familial Mediterranean fever For arresting the progression of neurologic disability caused by chronic progressive multiple sclerosis. For the treatment of Behcet's Syndrome. |
||||
10730 | Colistimethate | Sodium | INJECTION, POWDER | 1,000,000 U | PARENTERAL | J01XB01 | Hospital use only | |||
Complete probiotic for kids | SHACHET | KIDILACT | ||||||||
Complete probiotic_1 | CAPSULE | ORAL | FAMILACT | |||||||
354 | Conjugated Estrogens | TABLET | 1.25 mg | ORAL | G03CA57 | estromarine, premarine | ||||
341 | Co-trimoxazole | INJECTION, SOLUTION | 400/80 (Sulfamethoxazole 400mg+Trimethoprim 80mg)/5ml | INTRAVENOUS DRIP | J01EE01 | Hospital use only | ||||
372 | Cyproheptadine | HCl | TABLET | 4 mg | ORAL | R06AX02 | ||||
382 | Dantrolene | Sodium | INJECTION, POWDER | 20 mg | PARENTERAL | M03CA01 | Treatment of the malignant neuroleptic syndrome | Hospital use only; Orphan medicines | ||
52136 | Desloratadine | TABLET | 5 mg | ORAL | R06AX27 | |||||
1747 | Desmopressin | As Acetate | TABLET | 0.1 mg | ORAL | H01BA02 | ||||
400 | Dexamethasone | As Disodium Phosphate | INJECTION | 4 mg/ml | PARENTERAL | H02AB02 | ||||
398 | Dexamethasone | TABLET | 0.5 mg | ORAL | H02AB02 | |||||
17581 | Dexmedetomidine | As HCl | INJECTION, CONCENTRATE | 100mcg/ml, 2ml | PARENTERAL | N05CM18 | MEDONEX | Hospital use only | HIGH ALERT | |
405 | Dextromethorphan | HBr | SYRUP | 15 mg/5ml | ORAL | R05DA09 | OTC medicines | |||
408 | Dextromethorphan+Pseudoephedrine | SYRUP | (Dextromethorphan HBr 15mg+Pseudoephedrine HCl 30mg)/5ml | ORAL | R05DA20 | OTC medicines | ||||
413 | Dextrose | SOLUTION | 5%, 1000ml | INTRAVENOUS DRIP | B05BA03 | |||||
411 | Dextrose | INJECTION, SOLUTION | 10%, 500ml | INTRAVENOUS DRIP | B05BA03 | |||||
15951 | Dextrose | INJECTION, SOLUTION | 20% , 50ml | INTRAVENOUS DRIP | B05CX03 | HIGH ALERT | ||||
5746 | Dextrose | INJECTION, SOLUTION | 5%, 500ml | INTRAVENOUS DRIP | B05BA03 | |||||
15952 | Dextrose | INJECTION, SOLUTION, CONCENTRATE | 50%, 50ml | INTRAVENOUS DRIP | B05CX01 | HIGH ALERT | ||||
392 | Dextrose/ NaCl | INJECTION, SOLUTION | Dextrose 5% NaCl 0.9% Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/100 ml, 1000ml | INTRAVENOUS DRIP | B05BB02 | |||||
393 | Dextrose/ NaCl | INJECTION, SOLUTION | Dextrose 5% NaCl 0.9% Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/100 ml, 500ml | INTRAVENOUS DRIP | B05BB03 | |||||
395 | Dextrose/ NaCl | INJECTION, SOLUTION | Dextrose 3.33% NaCl 0.3% Dextrose anhydrous or monohydrate Eq. to 3.33% Dextrose/100 ml, 1000ml | INTRAVENOUS DRIP | B05BB02 | |||||
4907 | Dextrose/ NaCl | INJECTION, SOLUTION | Dextrose 3.33% NaCl 0.3% Dextrose anhydrous or monohydrate Eq. to 3.33% Dextrose/100 ml, 500ml | INTRAVENOUS DRIP | B05BB03 | |||||
418 | Diazepam | INJECTION | 5 mg/ml, 2ml | PARENTERAL | N05BA01 | |||||
419 | Diazepam | TABLET | 2 mg | ORAL | N05BA01 | |||||
420 | Diazepam | TABLET | 5 mg | ORAL | N05BA01 | |||||
427 | Diclofenac | Sodium | SUPPOSITORY | 100 mg | RECTAL | M01AB05 | ||||
428 | Diclofenac | Sodium | SUPPOSITORY | 50 mg | RECTAL | M01AB05 | ||||
1464 | Diclofenac | Sodium | SUPPOSITORY | 100 mg | RECTAL | M01AB05 | ||||
1993 | Diclofenac | Sodium | CAPSULE, EXTENDED RELEASE | 100 mg | ORAL | M01AB05 | ||||
429 | Dicyclomine | HCl | TABLET | 10 mg | ORAL | A03AA07 | ||||
431 | Dicyclomine | HCl | INJECTION | 10 mg/ml, 2ml | PARENTERAL | A03AA07 | ||||
436 | Digoxin | TABLET | 0.25 mg | ORAL | C01AA05 | |||||
438 | Digoxin | INJECTION | 0.25 mg/ml | PARENTERAL | C01AA05 | Hospital use only | HIGH ALERT | |||
447 | Diltiazem | HCl | TABLET | 60 mg | ORAL | C08DB01 | ||||
1472 | Diltiazem | HCl | TABLET, EXTENDED RELEASE | 120 mg | ORAL | C08DB01 | ||||
448 | Dimenhydrinate | TABLET | 50 mg | ORAL | OTC medicines | |||||
453 | Diphenhydramine | HCl | INJECTION | 50 mg/ml | PARENTERAL | R06AA02 | ||||
454 | Diphenhydramine | HCl | SOLUTION | 12.5 mg/5ml, 60 ml | ORAL | R06AA02 | OTC medicines | |||
456 | Diphenhydramine+Ammonium chloride | SYRUP | (Diphenhydramine HCl 12.5mg + Ammonium chloride 125mg) / 5ml | ORAL | R06AA52 | |||||
457 | Diphenoxylate | HCl | TABLET | 2.5 mg (Diphenoxylate HCl 2.5mg+Atropine sulfate 25mcg) | ORAL | A07DA01 | ||||
20686 | Dobutamine | INJECTION, SOLUTION | 12.5 mg/ml, 20ml | PARENTERAL | C01CA07 | As HCL | Hospital use only | HIGH ALERT | ||
6754 | Domperidone | As Maleate | TABLET | 10 mg | ORAL | A03FA03 | ||||
1927 | Donepezil | HCl | TABLET | 5 mg | ORAL | N06DA02 | YASNAL, ARICEPT | |||
1928 | Donepezil | HCl | TABLET | 10 mg | ORAL | N06DA02 | YASNAL, ARICEPT | |||
468 | Dopamine | HCl | INJECTION | 40 mg/ml | PARENTERAL | C01CA04 | Hospital use only | HIGH ALERT | ||
1259 | Doxepin | As HCl | CAPSULE | 25 mg | ORAL | N06AA12 | ||||
470 | Doxepin | As HCl | CAPSULE | 10 mg | ORAL | N06AA12 | ||||
474 | Doxycycline | As Monohydrate | CAPSULE | 100 mg | ORAL | J01AA02 | ||||
18430 | Duloxetine | As HCl | CAPSULE, DELAYED RELEASE | 20 mg | ORAL | N06AX21 | ||||
482 | Enalapril | TABLET | 20 mg | ORAL | C09AA02 | |||||
483 | Enalapril | TABLET | 5 mg | ORAL | C09AA02 | |||||
2043 | Enoxaparin | Sodium | INJECTION | 40mg (100 mg/ml, 0.4ml) | PARENTERAL | B01AB05 | HIGH ALERT | |||
2292 | Enoxaparin | Sodium | INJECTION | 60mg (100 mg/ml, 0.6 ml) | PARENTERAL | B01AB05 | HIGH ALERT | |||
486 | Ephedrine | HCl | INJECTION | 50 mg/ml | PARENTERAL | R03CA02 | Hospital use only | HIGH ALERT | ||
1489 | Epinephrine | As Acid Tartrate or As HCl | INJECTION | 1 mg/ml | PARENTERAL | C01CA24 | Hospital use only | HIGH ALERT* | ||
10484 | Epinephrine | As HCl | INJECTION | 0.1mg/ml | PARENTERAL | C01CA24 | HIGH ALERT* | |||
52289 | Epoetin | INJECTION | 20000 U/ ml, 0.5 ml | PARENTERAL | B03XA01 | Treatment of anemia | ||||
52263 | Epoetin | INJECTION | 4000 U/ 0.3 ml | PARENTERAL | B03XA01 | Treatment of anemia | ||||
496 | Erythromycin | As Ethylsuccinate | TABLET | 400 mg | ORAL | J01FA01 | ||||
497 | Erythromycin | As Ethylsuccinate | POWDER, FOR SUSPENSION | 200 mg/5ml | ORAL | J01FA01 | ||||
499 | Erythromycin | OINTMENT | 0.5% | OPHTHALMIC | S01AA17 | |||||
8968 | Escitalopram | As Oxalate | TABLET | 10 mg | ORAL | N06AB10 | Antidepressant, Anxiety disorder | |||
502 | Estradiol | Valerate | INJECTION | 10 mg/ml | PARENTERAL | G03CA03 | ||||
17247 | Etherified Starch | INJECTION, SOLUTION | 6%, 500 ml | PARENTERAL | B05AA07 | VOLUVEN, VOLSTARCH | ||||
1501 | Etomidate | INJECTION | 2 mg/ml, 10ml | PARENTERAL | N01AX07 | Hospital use only | HIGH ALERT LOOK ALIKE | |||
532 | Expectorant | SYRUP | (Guaifenesin 100mg + Chlorpheniramine maleate 2mg + Pseudoephedrine HCl 30 mg ) / 5ml | ORAL | R05CA10 | OTC medicines | ||||
527 | Famotidine | TABLET | 20 mg | ORAL | A02BA03 | OTC medicines | ||||
528 | Famotidine | TABLET | 40 mg | ORAL | A02BA03 | |||||
7830 | Fentanyl | As Citrate | INJECTION | 50 mcg/ml, 2ml | PARENTERAL | N01AH01 | Hospital use only | HIGH ALERT* | ||
531 | Ferrous | sulfate | TABLET | 50 mg Fe Elemental II | ORAL | OTC medicines | ||||
7251 | Fexofenadine | HCl | TABLET | 60 mg | ORAL | R06AX26 | OTC medicines | |||
6751 | Fexofenadine | HCl | TABLET | 120 mg | ORAL | R06AX26 | OTC medicines | |||
535 | Finasteride | TABLET | 5 mg | ORAL | G04CB01 | |||||
1872 | Finasteride | TABLET | 1 mg | ORAL | G04CB01 | |||||
536 | Flecainide | Acetate | TABLET | 100 mg | ORAL | C01BC04 | ||||
537 | Fluconazole | CAPSULE | 100 mg | ORAL | J02AC01 | |||||
538 | Fluconazole | CAPSULE | 150 mg | ORAL | J02AC01 | |||||
540 | Fluconazole | CAPSULE | 50 mg | ORAL | J02AC01 | |||||
8529 | Fluconazole | INJECTION | 2 mg/ml, 100ml | PARENTERAL | J02AC01 | Hospital use only. | ||||
543 | Fludrocortisone | Acetate | TABLET | 0.1 mg | ORAL | H02AA02 | ||||
545 | Fluocinolone | Acetonide | OINTMENT | 0.025% | TOPICAL | D07AC04 | ||||
551 | Fluoxetine | As HCl | CAPSULE | 20 mg | ORAL | N06AB03 | ||||
1512 | Fluoxetine | As HCl | CAPSULE | 10 mg | ORAL | N06AB03 | ||||
1827 | Fluvoxamine | Maleate | TABLET | 50 mg | ORAL | N06AB08 | ||||
562 | Folic Acid | TABLET | 1 mg | ORAL | B03BB01 | |||||
1948 | Folic Acid | TABLET | 5 mg | ORAL | B03BB01 | |||||
51896 | Furosemide | INJECTION, SOLUTION | 10 mg/ml, 2 ml | INTRAVENOUS DRIP | C03CA01 | Lasix® | LOOK ALIKE | |||
2134 | Furosemide | INJECTION, SOLUTION | 10 mg/ml, 4 ml | INTRAVENOUS DRIP | C03CA01 | Lasix® | ||||
571 | Furosemide | TABLET | 40 mg | ORAL | C03CA01 | |||||
572 | Gabapentin | CAPSULE | 100 mg | ORAL | N03AX12 | Treatment of amyotrophic lateral sclerosis. | ||||
573 | Gabapentin | CAPSULE | 300 mg | ORAL | N03AX12 | Treatment of amyotrophic lateral sclerosis. | ||||
584 | Gemfibrozil | CAPSULE | 300 mg | ORAL | C10AB04 | |||||
587 | Gentamicin | As Sulfate | INJECTION | 10 mg/ml, 2ml | PARENTERAL | J01GB03 | ||||
589 | Gentamicin | As Sulfate | SOLUTION/ DROPS | 3 mg/ml | OPHTHALMIC | S03AA06 | ||||
588 | Gentamicin | As Sulfate | OINTMENT | 3 mg/g | OPHTHALMIC | S01AA11 | ||||
590 | Gentamicin | As Sulfate | INJECTION | 40 mg/ml | PARENTERAL | J01GB03 | ||||
595 | Glibenclamide | TABLET | 5 mg | ORAL | A10BB01 | GLYBURIDE®, DAONIL® | Type 2 Diabetes Mellitus | |||
19418 | Gliclazide | TABLET, EXTENDED RELEASE | 60 mg | ORAL | A10BB09 | Diabezid® | Type 2 Diabetes Mellitus | HIGH ALERT | ||
1523 | Gliclazide | TABLET | 80 mg | ORAL | A10BB09 | Diabezid® | Type 2 Diabetes Mellitus | HIGH ALERT | ||
5442 | Gliclazide | TABLET, EXTENDED RELEASE | 30 mg | ORAL | A10BB09 | Diabezid® | Type 2 Diabetes Mellitus | HIGH ALERT | HIGH ALERT | |
487 | Glycerin | SUPPOSITORY | 2 g | RECTAL | A06AX01 | OTC medicines | Equal to 1.4 g Glycerin | |||
2054 | Glycerin | SUPPOSITORY | 1 g | RECTAL | A06AX01 | OTC medicines | ||||
614 | Guaifenesin | SYRUP | 100 mg/5ml | ORAL | R05CA03 | OTC medicines | ||||
617 | Haloperidol | TABLET | 0.5 mg | ORAL | N05AD01 | |||||
619 | Haloperidol | TABLET | 5 mg | ORAL | N05AD01 | |||||
620 | Haloperidol | As Lacate | INJECTION | 5 mg/ml | PARENTERAL | N05AD01 | HIGH ALERT | |||
622 | Hematinic | CAPSULE | VIT. B12 15mcg+Ferrous Fumarate 350 mg+VIT.C 150mg+Folic Acid 1mg | ORAL | B03AE02 | OTC medicines | ||||
7196 | Hemodialysis Concentrated II, Acidic | SOLUTION, CONCENTRATE | (Na+3710mEq + Mg2+35mEq + K+ 70mEq + Ca2+ 87.5mEq + Cl- 3902.5 mEq + CH3Coo- 122.5 mEq + Dextrose 70 g)/ L Dextrose anhydrous or monohydrate Eq. to 70 g Dextrose/5000 ml | UNASSIGNED | B05ZA | Hospital use only | HIGH ALERT | |||
624 | Heparin | Sodium | INJECTION | 5000 U/ml | PARENTERAL | B01AB01 | Hospital use only | HIGH ALERT* | ||
632 | Hydralazine | HCl | INJECTION, POWDER | 20 mg | PARENTERAL | C02DB02 | Hospital use only | |||
636 | Hydrochlorothiazide | TABLET | 50 mg | ORAL | C03AA03 | Oedema, Hypertension | ||||
637 | Hydrocortisone | As Sodium succinate | INJECTION, POWDER | 100 mg | PARENTERAL | H02AB09 | ||||
639 | Hydrocortisone | Acetate | OINTMENT | 1% | OPHTHALMIC | S01BA02 | ||||
640 | Hydrocortisone | Acetate | OINTMENT | 1% | TOPICAL | D07AA02 | ||||
1825 | Hydroxychloroquine | Sulfate | TABLET | 200 mg | ORAL | P01BA02 | ||||
1917 | Hydroxyprogesterone | Caproate | INJECTION | 250 mg/ml | PARENTERAL | PROLOTON, FEMOLIFE | ||||
650 | Hydroxyzine | HCl | SYRUP | 10 mg/5ml | ORAL | N05BB01 | ||||
651 | Hydroxyzine | HCl | TABLET | 10 mg | ORAL | N05BB01 | ||||
652 | Hydroxyzine | HCl | TABLET | 25 mg/ml | ORAL | N05BB01 | ||||
654 | Hyoscine-n-butyl | Bromide | TABLET | 10 mg | ORAL | A03BB01 | ||||
655 | Hyoscine-n-butyl | Bromide | INJECTION | 20 mg/ml | PARENTERAL | A03BB01 | LOOK ALIKE | |||
657 | Ibuprofen | SUSPENSION | 100 mg/5ml | ORAL | M01AE01 | OTC medicines | ||||
658 | Ibuprofen | TABLET | 200 mg | ORAL | M01AE01 | OTC medicines | ||||
659 | Ibuprofen | TABLET | 400 mg | ORAL | M01AE01 | OTC medicines | ||||
1876 | Imipenem+Cilastatin | INJECTION, POWDER | Imipenem(as Monohydrate) 500 mg + Cilastatin(as Sodium) 500 mg | PARENTERAL | J01DH51 | Hospital use only | ||||
669 | Indometacin | CAPSULE | 25 mg | ORAL | M01AB01 | |||||
670 | Indometacin | SUPPOSITORY | 50 mg | RECTAL | M01AB01 | |||||
674 | Insulin (Regular) | INJECTION | 100 IU/ml | PARENTERAL | A10AB01 | HIGH ALERT* | ||||
20306 | Insulin Aspart | INJECTION, FELX PEN | 100 IU/ml | PARENTERAL | A10AB05 | NOVORAPID | HIGH ALERT* | |||
50575 | Insulin Aspart (soluble + crystallised) | INJECTION, FLEX PEN | 30% soluble Insulin Aspart + 70% Insulin Aspart crystallised with Protamine, 100 IU/ml , 3 ml | PARENTERAL | A10AB05 | NOVOMIX | HIGH ALERT* | |||
12837 | Insulin Detemir | INJECTION, FLEX PEN | 100 IU/ml | PARENTERAL | A10AE05 | LEVEMIR | HIGH ALERT | |||
7338 | Insulin Glargine | INJECTION, FLEX PEN | 100 IU/ml, 3 ml | PARENTERAL | A10AE01 | LANTUS | Diabetes Mellitus | HIGH ALERT* | ||
676 | Insulin Isophane | INJECTION | 100 IU/ml | PARENTERAL | A10AE01 | NPH | HIGH ALERT | |||
2517 | Iodixanol | INJECTION | 320 mgI/ml, 50 ml | PARENTERAL | V08AB09 | VISIPAQUE | HIGH ALERT | |||
2063 | Iohexol | INJECTION | 350 mgI/ml (755 mg/ml) | PARENTERAL | V08AB02 | OMNIPAQUE | HIGH ALERT | |||
2059 | Iohexol | INJECTION | 300 mgI/ml, 50 ml (647 mg/ml) | PARENTERAL | V08AB02 | OMNIPAQUE | HIGH ALERT | |||
708 | Ipratropium | Bromide | INHALER | 20 mcg/dose | RESPIRATORY | R03BB01 | ATROVENT | |||
50390 | Ipratropium+Salbutamol | NEBULISATION | (Ipratropium bromide 200 mcg + Salbutamol ( As sulfate ) 1 mg)/ml, 2.5 ml | RESPIRATORY | R03AL02 | DUOLIN | SOUND ALIKE | |||
530 | Iron | SOLUTION/ DROPS | 25 mg/ml | ORAL | B03AA02 | OTC medicines | ||||
2049 | Iron / Folic Acid | As Fumarate | TABLET | Iron 60 mg + Folic Acid 400 mcg | ORAL | OTC medicines | ||||
1943 | Isoflurane | INHALANT | 100 ml | RESPIRATORY | N01AB06 | Hospital use only | HIGH ALERT DOSE METRED | |||
721 | Isoxsuprine | HCl | TABLET | 10 mg | ORAL | C04AA01 | ||||
723 | Ketamine | As HCl | INJECTION | 50 mg/ml, 10 ml | PARENTERAL | N01AX03 | Hospital use only | HIGH ALERT | ||
726 | Ketoconazole | TABLET | 200 mg | ORAL | J02AB02 | |||||
17972 | Ketorolac | Trometamol | INJECTION, SOLUTION | 30 mg/ml | PARENTERAL | M01AB15 | Hospital use only | |||
727 | Ketotifen | As Fumarate | TABLET | 1 mg | ORAL | R06AX17 | ||||
728 | Ketotifen | As Fumarate | SYRUP | 1 mg/5 ml | ORAL | R06AX17 | ||||
728 | Ketotifen | As Fumarate | SYRUP | 1 mg/5 ml, 60 ml | ORAL | R06AX17 | ||||
8004 | Labetalol | HCl | INJECTION | 5 mg/ml, 20ml | PARENTERAL | C07AG01 | Hospital use only | HIGH ALERT | ||
731 | Lactulose | SYRUP | 10 g/15 ml, 240 ml | ORAL | A06AD11 | |||||
733 | Lamotrigine | TABLET | 50 mg | ORAL | N03AX09 | |||||
L-Carnitine | TABLET | 500 mg | ORAL | A16AA01 | ||||||
220 | L-Carnitine | TABLET | 250 mg | ORAL | A16AA01 | |||||
16641 | Levetiracetam | INJECTION, SOLUTION | 500 mg/100 ml | PARENTERAL | N03AX14 | LEVEBEL | Hospital use only | In Sodium Chloride | ||
5973 | Levetiracetam | TABLET | 250 mg | ORAL | N03AX14 | LEVEBEL | ||||
16641 | Levetiracetam | INJECTION, SOLUTION | 500 mg/100 ml | PARENTERAL | N03AX14 | LEVEBEL | Hospital use only | In Sodium Chloride | ||
5977 | Levetiracetam | TABLET | 500 mg | ORAL | N03AX14 | |||||
746 | Levodopa+Benserazide | TABLET | Levodopa 200 mg+Benserazide (as Hydrochloride) 50 | ORAL | N04BA02 | NORESTOR, MADOPAR | ||||
747 | Levodopa+Carbidopa | TABLET | Levodopa 100 mg+Carbidopa (as Monohydrate) 10 mg | ORAL | N04BA02 | |||||
16320 | Levofloxacin | INJECTION , SOLUTION | 5 mg/ml, 100ml | INTRAVENOUS DRIP | J01MA12 | Hospital use only | ||||
7183 | Levofloxacin | TABLET | 500 mg | ORAL | J01MA12 | TAVANEX | ||||
19797 | Levofloxacin | TABLET | 750 mg | ORAL | J01MA12 | TAVANEX | ||||
751 | Levothyroxine | Sodium | TABLET | 100 mcg | ORAL | H03AA01 | ||||
2950 | Lidocaine | SPRAY | 10 mg/dose, 100ml | TOPICAL | D04AB01 | |||||
753 | Lidocaine | HCl | INJECTION | 2%, 5ml | PARENTERAL | C01BB01 | Hospital use only | HIGH ALERT* | ||
756 | Lidocaine | HCl | GEL | 2% | TOPICAL | D04AB01 | OTC medicines | |||
9415 | Lidocaine+Prilocaine | CREAM | 30 g (Lidocaine 2.5% + Prilocaine 2.5%) | TOPICAL | N01BB52 | XAYLA-P | ||||
8300 | Linezolid | TABLET | 600 mg | ORAL | J01XX08 | |||||
50114 | Linezolid | INJECTION, SOLUTION | 2 mg/ml, 300ml | PARENTERAL | J01XX08 | Hospital use only | ||||
1165 | Lipid Infusion | INJECTION, SOLUTION | 10% | INTRAVENOUS DRIP | B05BA02 | HIGH ALERT | ||||
767 | Lithium | Carbonate | TABLET | 300 mg | ORAL | N05AN01 | ||||
1848 | Loperamide | HCl | TABLET | 2 mg | ORAL | A07DA03 | OTC medicines | |||
6275 | Loperamide | HCl | SOLUTION | 1 mg/5ml | ORAL | A07DA03 | OTC medicines | |||
1574 | Loratadine | TABLET | 10 mg | ORAL | R06AX13 | OTC medicines | ||||
771 | Lorazepam | TABLET | 1 mg | ORAL | N05BA06 | |||||
772 | Lorazepam | TABLET | 2 mg | ORAL | N05BA06 | |||||
1822 | Losartan | Potassium | TABLET | 25 mg | ORAL | C09CA01 | ||||
1933 | Losartan | Potassium | TABLET | 50 mg | ORAL | C09CA01 | ||||
8256 | Losartan+Hydrochlorothiazide | TABLET | Losartan Potassium 50mg + Hydrochlorothiazide 12.5mg | ORAL | C03AX01 | |||||
777 | Magnesium Hydroxide | SUSPENSION | 8% | ORAL | A02AA04 | OTC medicines | ||||
3823 | Magnesium Sulfate | INJECTION | 50%, 10ml | PARENTERAL | A12CC02 | Hospital use only | HIGH ALERT* VITAL | |||
8269 | Magnesium Sulfate | INJECTION | 20%, 10ml | PARENTERAL | A12CC02 | HIGH ALERT* VITAL | ||||
17832 | Magnesium Sulfate | INJECTION | 20%, 50ml | PARENTERAL | A12CC02 | HIGH ALERT* VITAL | ||||
22689 | Magnesium Sulfate | INJECTION | 50%, 50 ml | PARENTERAL | A12CC02 | Hospital use only | HIGH ALERT* VITAL | |||
782 | Mannitol | INJECTION, SOLUTION | 20%, 500ml | INTRAVENOUS DRIP | B05BC01 | Hospital use only | ||||
784 | Maprotiline | HCl | TABLET | 75 mg | ORAL | N06AA21 | ||||
787 | Mebeverine | HCl | TABLET | 135 mg | ORAL | A03AA04 | ||||
9532 | Mebeverine | HCl | TABLET | 135 mg | ORAL | A03AA04 | MEBACTO, COLOFAC | |||
792 | Medroxyprogesterone | Acetate | TABLET | 5 mg | ORAL | G03DA02 | ||||
794 | Mefenamic Acid | CAPSULE | 250 mg | ORAL | M01AG01 | |||||
51516 | Meglumine Compound | SOLUTION | Meglumine Diatrizoate 66%+Sodium Diatrizoate 10%, 120ml | ORAL | V08AA01 | HIGH ALERT | ||||
799 | Meglumine Compound | SOLUTION | Meglumine Diatrizoate 66%+Sodium Diatrizoate 10%, 20 ml | ORAL | V08AA01 | HIGH ALERT | ||||
271 | Meloxicam | TABLET | 15 mg | ORAL | M01AC06 | MOBIC | ||||
5452 | Meloxicam | TABLET | 7.5 mg | ORAL | M01AC06 | MOBIC | ||||
9203 | Memantine | HCl | TABLET | 5 mg | ORAL | N06DX01 | ||||
10792 | Memoral | CAPSULE | ORAL | |||||||
3283 | Meropenem | As Trihydrate | INJECTION, POWDER | 500 mg | PARENTERAL | J01DH02 | Management of acute pulmonary exacerbations, in cystic fibrosis patients, due to respiratory tract infection with susceptible organisms. | Hospital use only. | ||
5629 | Meropenem | As Trihydrate | INJECTION, POWDER | 1000 mg | PARENTERAL | J01DH02 | Management of acute pulmonary exacerbations, in cystic fibrosis patients, due to respiratory tract infection with susceptible organisms. | Hospital use only. | ||
817 | Metformin | HCl | TABLET | 500 mg | ORAL | A10BA02 | GLUCOPHAGE | HIGH ALERT | ||
819 | Methadone | HCl | INJECTION | 5 mg/ml | PARENTERAL | N07BC02 | Hospital use only | HIGH ALERT* | ||
821 | Methimazole | TABLET | 5 mg | ORAL | H03BB02 | |||||
822 | Methocarbamol | INJECTION | 100 mg/ml, 10ml | PARENTERAL | M03EA03 | LOOK ALIKE | ||||
823 | Methocarbamol | TABLET | 500 mg | ORAL | M03EA03 | |||||
52098 | Methotrexate | As Sodium | INJECTION, SOLUTION | 10 mg/ml | PARENTERAL | L01BA01 | EBETREX | HIGH ALERT | ||
832 | Methyldopa | TABLET | 250 mg | ORAL | C02AB02 | |||||
834 | Methylergonovine | Maleate | INJECTION | 0.2 mg/ml | PARENTERAL | G02AB01 | ||||
835 | Methylprednisolone | Acetate | INJECTION | 40 mg/ml | PARENTERAL | H02AB04 | DEPOMEDROL | |||
836 | Methylprednisolone | As Sodium succinate | INJECTION, POWDER | 500 mg | PARENTERAL | H02AB04 | Hospital use only | |||
841 | Metoclopramide | HCl | TABLET | 10 mg | ORAL | A03FA01 | PLASIL | |||
840 | Metoclopramide | HCl | SOLUTION/ DROPS | 4 mg/ml, 15ml | ORAL | A03FA01 | PLASIL | |||
839 | Metoclopramide | HCl | INJECTION | 5 mg/ml, 2ml | PARENTERAL | A03FA01 | ||||
11871 | Metoprolol | Succinate | TABLET, EXTENDED RELEASE | 47.5 mg | ORAL | C07AB02 | ||||
2319 | Metoprolol | Tartrate | TABLET | 50 mg | ORAL | C07AB02 | METORAL | |||
2073 | Metoprolol | Tartrate | INJECTION | 1mg/ml, 5ml | PARENTERAL | C07AB02 | Hospital use only | |||
843 | Metronidazole | INJECTION, SOLUTION | 5 mg/ml, 100ml | INTRAVENOUS DRIP | J01XD01 | Hospital use only | ||||
844 | Metronidazole | As Benzoate | SUSPENSION | 125 mg/5ml | ORAL | P01AB01 | ||||
845 | Metronidazole | TABLET | 250 mg | ORAL | P01AB01 | |||||
846 | Metronidazole | SUPPOSITORY | 500 mg | VAGINAL | G01AF01 | |||||
852 | Midazolam | As HCl | INJECTION | 5 mg/ml | PARENTERAL | N05CD08 | Treatment of bouts of increased seizure activity in selected refractory patients with epilepsy who are on stable regimens of anti-epileptic drugs and who require intermittent use of midazolam | Hospital use only | HIGH ALERT | |
1591 | Midazolam | As HCl | INJECTION | 5 mg/ml, 3ml | PARENTERAL | N05CD08 | Treatment of bouts of increased seizure activity in selected refractory patients with epilepsy who are on stable regimens of anti-epileptic drugs and who require intermittent use of midazolam | Hospital use only | ||
50327 | Midodrine | HCl | TABLET | 2. 5 mg | ORAL | C01CA17 | Hospital use only; Orphan medicines | |||
8095 | Misoprostol | TABLET | 200 mcg | ORAL | G02AD06 | Treatment of intrauterine fetal death not accompanied by complete expulsion of the products of conception in the second and third trimesters of pregnancy. | Hospital use only | DOSE METERED | ||
857 | Mitomycin | INJECTION, POWDER | 2 mg | PARENTERAL | L01DC03 | |||||
21807 | Mometasone | Furoate | SPRAY, SUSPENSION | 0.05% | NASAL | R01AD09 | ||||
1895 | Montelukast | As Sodium | TABLET, CHEWABLE | 5 mg | ORAL | R03DC03 | ||||
6043 | Montelukast | As Sodium | TABLET | 10 mg | ORAL | R03DC03 | ||||
1600 | Morphine | Sulfate | INJECTION | 10 mg/ml | PARENTERAL | N02AA01 | Hospital use only | HIGH ALERT* | ||
Multivitamin | SYRUP | ORAL | A11AA | |||||||
Multivitamin | DROPS, SOLUTION | ORAL | A11AA | |||||||
Multivitamin | EFFERVESENT TABLET | ORAL | A11AA | |||||||
Multivitamin | TABLET | ORAL | A11AA | |||||||
867 | Multivitamin Therapeutic | CAPSULE | Vit.A 25000 IU+Vit.B1 20 mg+Vit.B2 5mg+Nicotinamide50 mg+Vit.B6 10mg+Vit.B12 5mcg+Vit.C 150mg+Biotin 0.25mg+Vit.D 1000IU+ Vit.E 10mg(IU)+Folic Acid 1mg+Calcium Pantothenate 11.6mg+Ca 100mg +Mg(As MgO) 5mg +Mn 0.5mg+Mo 0.1mg+Iron 10mg+Zn 0.5mg+P 77.27mg+Cu | ORAL | A11AA | |||||
Multivitamine for kidney disease | TABLET | ORAL | NEPHROVIT, NEPHROTONIC | |||||||
875 | Mupirocin | OINTMENT | 0.02 | TOPICAL | D06AX09 | |||||
1341 | Naloxone | HCl | INJECTION | 0.4 mg/ml | PARENTERAL | V03AB15 | Hospital use only | |||
884 | Nandrolone | Decanoate | INJECTION | 25 mg/ml | PARENTERAL | A14AB01 | ||||
889 | Naproxen | TABLET | 250 mg | ORAL | M01AE02 | |||||
1606 | Naproxen | TABLET, DELAYED RELEASE | 500 mg | ORAL | M01AE02 | |||||
893 | Neostigmine | Methylsulfate | INJECTION | 0.5 mg/ml | PARENTERAL | N07AA01 | Hospital use only | |||
895 | Neostigmine | Methylsulfate | INJECTION | 2.5 mg/ml | PARENTERAL | N07AA01 | Hospital use only | |||
6459 | Nicorandil | TABLET | 10 mg | ORAL | C01DX16 | |||||
907 | Nitrofurantoin | TABLET | 100 mg | ORAL | J01XE01 | |||||
913 | Nitroglycerin | TABLET, EXTENDED RELEASE | 2.6 mg | ORAL | C01DA02 | |||||
1812 | Nitroglycerin | INJECTION | 5 mg/ml | PARENTERAL | C01DA02 | Hospital use only | ||||
915 | Nitroglycerin | TABLET, EXTENDED RELEASE | 6.4 mg | ORAL | C01DA02 | |||||
914 | Nitroglycerin | INJECTION | 5 mg/ml, 2ml | PARENTERAL | C01DA02 | Hospital use only | ||||
1832 | Nitroglycerin | SPRAY | 400 mcg/dose | SUBLINGUAL | C01DA02 | |||||
1620 | Norepinephrine | As Bitartrate | INJECTION | 0.1% | PARENTERAL | C01CA03 | Hospital use only | HIGH ALERT VITAL | ||
921 | Nortriptyline | As HCl | TABLET | 10 mg | ORAL | N06AA10 | ||||
922 | Nortriptyline | As HCl | TABLET | 25 mg | ORAL | N06AA10 | ||||
925 | Nystatin | POWDER, FOR SUSPENSION | 100,000 U/ml | LOCAL ORAL | A07AA02 | |||||
926 | Nystatin | TABLET | 500,000 U | ORAL | A07AA02 | |||||
928 | Octreotide | As Acetate | INJECTION | 50 mcg/ml | PARENTERAL | H01CB02 | Treatment of acromegaly. Treatment of diarrhea associated with vasoactive intestinal peptide tumors (VIPoma). Treatment of severe diarrhea and flushing associated with malignant carcinoid tumors. |
|||
1907 | Olanzapine | TABLET | 5 mg | ORAL | N05AH03 | |||||
OMEGA-3 | CAPSULE | 1000 mg | ||||||||
931 | Omeprazole | CAPSULE, DELAYED RELEASE PELLETS | 20 mg | ORAL | A02BC01 | OTC medicines | ||||
2091 | Ondansetron | As HCl | INJECTION | 2 mg/ml | PARENTERAL | A04AA01 | LOOK ALIKE | |||
2092 | Ondansetron | As HCl | INJECTION | 2 mg/ml, 4 ml | PARENTERAL | A04AA01 | ||||
933 | ORS | POWDER, FOR SOLUTION | Na 75 mmol/Lit + K 20 mmol/Lit + Cl 65 mmol/Lit + Citrate 10 mmol/Lit + Dextrose 75 mmol/Lit | ORAL | ||||||
934 | Oxazepam | TABLET | 10 mg | ORAL | N05BA04 | |||||
935 | Oxybutynin | HCl | TABLET | 5 mg | ORAL | G04BD04 | ||||
939 | Oxytocin | INJECTION | 10 U/ml | PARENTERAL | H01BB02 | Hospital use only | HIGH ALERT | |||
2332 | Pantoprazole | As Sodium sesquihydrate | TABLET, DELAYED RELEASE | 20 mg | ORAL | A02BC02 | ||||
2333 | Pantoprazole | As Sodium sesquihydrate | TABLET, DELAYED RELEASE | 40 mg | ORAL | A02BC02 | ||||
2336 | Pantoprazole | As Sodium | INJECTION, POWDER, LYOPHILIZED | 40 mg | INTRAVENOUS DRIP | A02BC02 | ||||
970 | Pentoxifylline | TABLET, EXTENDED RELEASE | 400 mg | ORAL | C04AD03 | |||||
972 | Perphenazine | TABLET | 2 mg | ORAL | N05AB03 | |||||
1354 | Pethidine | HCl | INJECTION | 50 mg/ml | PARENTERAL | N02AB02 | Hospital use only | HIGH ALERT* | ||
11397 | Pethidine | HCl | INJECTION | 25 mg/ml | PARENTERAL | N02AB02 | Hospital use only | HIGH ALERT* | ||
976 | Phenazopyridine | HCl | TABLET | 100 mg | ORAL | G04BX06 | ||||
979 | Phenobarbital | TABLET | 100 mg | ORAL | N03AA02 | HIGH ALERT | ||||
982 | Phenobarbital | TABLET | 60 mg | ORAL | N03AA02 | HIGH ALERT | ||||
977 | Phenobarbital | As Sodium | INJECTION | 200 mg/ml | PARENTERAL | N03AA02 | Hospital use only | HIGH ALERT | ||
988 | Phenylephrine | HCl | SOLUTION/ DROPS | 0.25% | NASAL | R01AA04 | OTC medicines | |||
989 | Phenylephrine | HCl | SOLUTION/ DROPS | 0.5% | NASAL | R01AA04 | OTC medicines | |||
1635 | Phenylephrine | HCl | INJECTION | 10 mg/ml | PARENTERAL | C01CA06 | Hospital use only | HIGH ALERT | ||
993 | Phenytoin | Sodium | CAPSULE | 100 mg | ORAL | N03AB02 | ||||
6072 | Phenytoin | SUSPENSION | 125 mg/5ml | ORAL | N03AB02 | |||||
1637 | Phenytoin | Sodium | CAPSULE | 50 mg | ORAL | N03AB02 | ||||
995 | Phenytoin | Sodium | INJECTION | 50 mg/ml, 5ml | PARENTERAL | N03AB02 | Hospital use only | |||
14109 | Phosphate (organic) | INJECTION | 216 mg/ml, 20 ml | PARENTERAL | B05AX | Glycofos | ||||
2397 | Phosphate, Sodium | TABLET, EFFERVESCENT | NaH2PO4 1936 mg+ NaHCO3 350 mg+KHCO3 315 mg | ORAL | A12BA | |||||
5624 | Pioglitazone | As HCl | TABLET | 30 mg | ORAL | A10BG03 | HIGH ALERT | |||
3894 | Piperacillin+Tazobactam | INJECTION, POWDER | Piperacillin (as Sodium ) 4g + Tazobactam (as Sodium ) 500mg | PARENTERAL | J01CR05 | Hospital use only | ||||
2081 | Piperacillin+Tazobactam | INJECTION, POWDER | Piperacillin (as Sodium ) 2g + Tazobactam (as Sodium ) 250mg | PARENTERAL | J01CR05 | Hospital use only | ||||
1014 | Piracetam | TABLET | 800 mg | ORAL | N06BX03 | |||||
Plasma, Cryoprecipitate | INJECTION | PARENTERAL | B05AX03 | Blood component replacement | Hospital use only | Blood plasma (INN) | ||||
Platelet, Concentrated | INJECTION | PARENTERAL | B05AX02 | Blood component replacement | Hospital use only | Thrombocytes (INN) | ||||
2174 | Poly Ethylene Glycol | POWDER | 70 g | ORAL | A06AD15 | OTC medicines | ||||
8501 | Poractant Alfa | INJECTION, SUSPENSION | 80 mg/ ml, 3ml | INTRATRACHEAL | R07AA | CUROSURF | Hospital use only | |||
941 | Potassium Chloride Concentrated | INJECTION, SOLUTION, CONCENTRATE | 2 mEq/ml, 50 ml | INTRAVENOUS DRIP | B05XA01 | Hospital use only | HIGH ALERT* | |||
52379 | Potassium Chloride Concentrated | INJECTION, SOLUTION, CONCENTRATE | 2 mEq/ml, 10ml | INTRAVENOUS DRIP | B05XA01 | Hospital use only | HIGH ALERT* | |||
1034 | Povidone Iodine | SOLUTION | 1000 ml | TOPICAL | D08AG02 | OTC medicines | ||||
1036 | Povidone Iodine | SOLUTION | 7.5% | TOPICAL | D08AG02 | OTC medicines ; Surgical Scrub | ||||
6050 | Pramipexole | DiHCl | TABLET | 0.7 mg | ORAL | N04BC05 | SIFROL | |||
1042 | Prazosin | As HCl | TABLET | 1 mg | ORAL | C02CA01 | ||||
1043 | Prazosin | As HCl | TABLET | 5 mg | ORAL | C02CA01 | ||||
1044 | Prednisolone | TABLET | 50 mg | ORAL | H02AB06 | |||||
1045 | Prednisolone | TABLET | 5 mg | ORAL | H02AB06 | |||||
7239 | Pregabalin | CAPSULE | 75 mg | ORAL | N03AX16 | |||||
8526 | Pregabalin | CAPSULE | 50 mg | ORAL | N03AX16 | |||||
1058 | Progesterone | INJECTION | 50 mg/ml | PARENTERAL | G03DA04 | |||||
2082 | Progesterone | SUPPOSITORY | 400 mg | VAGINAL or RECTAL | G03DA04 | |||||
1060 | Promethazine | As HCl | SYRUP | 5 mg/5ml, 60ml | ORAL | R06AD02 | ||||
1061 | Promethazine | HCl | INJECTION | 25 mg/ml, 2ml | PARENTERAL | R06AD02 | HIGH ALERT | |||
1653 | Propofol | INJECTION, SOLUTION | 10 mg/ml, 20ml | PARENTERAL | N01AX10 | Hospital use only | HIGH ALERT DOSE METERED | |||
1067 | Propranolol | HCl | TABLET | 10 mg | ORAL | C07AA05 | ||||
1068 | Propranolol | HCl | TABLET | 40 mg | ORAL | C07AA05 | ||||
1949 | Propranolol | HCl | INJECTION | 1 mg/ml | PARENTERAL | C07AA05 | Hospital use only | HIGH ALERT | ||
7066 | Propranolol | HCl | TABLET | 20 mg | ORAL | C07AA05 | ||||
Prostatan | TABLET | ORAL | ||||||||
Pure protein | SACHET | |||||||||
6743 | Quetiapine | as Fumarate | TABLET | 25 mg | ORAL | N05AH04 | Antipsychotic | |||
Red Blood Cell | INJECTION | PARENTERAL | B05AX01 | Blood component replacement | Hospital use only | Erythrocytes (INN) | ||||
Red Blood Cell, Irradiated | INJECTION | PARENTERAL | B05AX01 | Blood component replacement | Hospital use only | Erythrocytes (INN) | ||||
Red Blood Cell, Irradiated and Washed | INJECTION | PARENTERAL | B05AX01 | Blood component replacement | Hospital use only | Erythrocytes (INN) | ||||
Red Blood Cell, Leucocyte Reduced and Irradiated | INJECTION (infusion) | PARENTERAL | B05AX01 | Blood component replacement | Hospital use only | Erythrocytes (INN) | ||||
Red Blood Cell, Leucocyte Reduced and Washed and Irradiated | INJECTION (infusion) | PARENTERAL | B05AX01 | Blood component replacement | Hospital use only | Erythrocytes (INN) | ||||
Red Blood Cell, Leukocyte Reduced | INJECTION | PARENTERAL | B05AX01 | Blood component replacement | Hospital use only | Erythrocytes (INN) | ||||
Red Blood Cell, Leukocyte Reduced and Washed | INJECTION | PARENTERAL | B05AX01 | Blood component replacement | Hospital use only | Erythrocytes (INN) | ||||
Red Blood Cell, Leukocyte Reduced and Washed | INJECTION | PARENTERAL | B05AX01 | Blood component replacement | Hospital use only | Erythrocytes (INN) | ||||
Red Blood Cell, Pediatric, Irradiated | INJECTION (infusion) | PARENTERAL | B05AX01 | Blood component replacement | Hospital use only | Erythrocytes (INN) | ||||
Red Blood Cell, Pediatric, Leucocyte Reduced | INJECTION (infusion) | PARENTERAL | B05AX01 | Blood component replacement | Hospital use only | Erythrocytes (INN) | ||||
Red Blood Cell, Pediatric, Washed | INJECTION (infusion) | PARENTERAL | B05AX01 | Blood component replacement | Hospital use only | Erythrocytes (INN) | ||||
Red Blood Cell, Pediatric, Washed and Irradiated | INJECTION (infusion) | PARENTERAL | B05AX01 | Blood component replacement | Hospital use only | Erythrocytes (INN) | ||||
Red Blood Cell, Washed | INJECTION (infusion) | PARENTERAL | B05AX01 | Blood component replacement | Hospital use only | Erythrocytes (INN) | ||||
52689 | Remdesivir | INJECTION, POWDER FOR SOLUTION | 100mg | PARENTERAL | ||||||
2183 | Remifentanil | INJECTION, POWDER | 2 mg | PARENTERAL | N01AH06 | Hospital use only | HIGH ALERT* | |||
58 | Reteplase | INJECTION, POWDER | 10.4 U | PARENTERAL | B01AD07 | Hospital use only | HIGH ALERT | |||
1101 | Rifampicin | CAPSULE | 150 mg | ORAL | J04AB02 | |||||
1103 | Rifampicin | CAPSULE | 300 mg | ORAL | J04AB02 | |||||
1107 | Ringer Lactate | INJECTION, SOLUTION | 500 ml (Na+130mEq + Ca++3mEq + K +4mEq + Cl-109mEq + Lactate 28mEq)/L | INTRAVENOUS DRIP | B05BB01 | Hospital use only | ||||
4864 | Ringers | INJECTION, SOLUTION | 500 ml (Na+147mEq + Ca++ 4.5mEq + K+4mEq +Cl-156mEq)/L) | INTRAVENOUS DRIP | B05BB01 | |||||
1104 | Ringers | INJECTION, SOLUTION | 1000 ml (Na+147mEq + Ca++ 4.5mEq + K+4mEq +Cl-156mEq)/L) | INTRAVENOUS DRIP | B05BB01 | |||||
1774 | Risperidone | TABLET | 2 mg | ORAL | N05AX08 | |||||
1773 | Risperidone | TABLET | 1 mg | ORAL | N05AX08 | |||||
50005 | Rivaroxaban | TABLET | 15 mg | ORAL | B01AF01 | Antithrombotic | HIGH ALERT | |||
22856 | Rivaroxaban | TABLET | 20 mg | ORAL | B01AF01 | Antithrombotic | HIGH ALERRT | |||
17597 | Rivaroxaban | TABLET | 10 mg | ORAL | B01AF01 | Antithrombotic | HIGH ALERT | |||
1998 | Rivastigmine | As Hydrogen Tartrate | CAPSULE | 1.5 mg | ORAL | N06DA03 | ||||
15068 | Salbutamol | INHALER | 100 mcg/dose, 200 dose | RESPIRATORY | R03AC02 | |||||
9897 | Salbutamol | As Sulfate | INHALER | 2.5 mg/2.5ml | RESPIRATORY | R03AC02 | ||||
4927 | Salmeterol+Fluticasone | AEROSOL, METERED | Salmeterol (as Xinafoate) 25mcg +Fluticasone Propionate 250mcg | RESPIRATORY | R03AK06 | SERETIDE | ||||
4795 | Salmeterol+Fluticasone | AEROSOL, METERED | Salmeterol(as Xinafoate) 25mcg + Fluticasone Propionate 125mcg | RESPIRATORY | R03AK06 | SERETIDE | ||||
1896 | Sertraline | As HCl | TABLET | 50 mg | ORAL | N06AB06 | ASENTRA | |||
21183 | Sevelamer | HCl | TABLET | 800 mg | ORAL | V03AE02 | RENAGEL | |||
1781 | Sildenafil | As Citrate | TABLET | 50 mg | ORAL | G04BE03 | ||||
1780 | Sildenafil | As Citrate | TABLET | 100 mg | ORAL | G04BE03 | ||||
1130 | Silver Sulfadiazine | CREAM | 10 mg/g, 50g | TOPICAL | D06BA01 | OTC medicines | ||||
1131 | Simethicone (Dimethicone Activated) | TABLET, CHEWABLE | 40 mg | ORAL | A07D | OTC medicines | ||||
22428 | Sitagliptin | As Phosphate | TABLET | 50 mg | ORAL | A10BH01 | ZITINE | Type 2 Diabetes Mellitus | HIGH ALERT | |
15754 | Sitagliptin+Metformin | TABLET | Sitagliptin (as Phosphate) 50 mg+ Metformin Hydrochloride 500 mg | ORAL | A10BD07 | ZIPMET, SIGOMET | Type 2 Diabetes Mellitus | HIGH ALERT | ||
Sodium Bicarbonate | TABLET | 500 mg | ORAL | |||||||
17833 | Sodium Bicarbonate | INJECTION | 7.5% | PARENTERAL | B05XA02 | Hospital use only | HIGH ALERT VITAL | |||
1139 | Sodium Bicarbonate concentrates | 650 mg | 650 mg | B05ZA | RENABAG | Not applicable | ||||
1139 | Sodium Bicarbonate concentrates | 650 mg | 650 mg | B05ZA | RENACART | Not applicable | ||||
6417 | Sodium Chloride | INJECTION, SOLUTION | 0.90% , 250ml | PARENTERAL | B05XA03 | NORMAL SALINE | ||||
1144 | Sodium Chloride | INJECTION, SOLUTION | 0.9%, 500ml | INTRAVENOUS DRIP | B05XA03 | NORMAL SALINE | ||||
1148 | Sodium Chloride | INJECTION, SOLUTION | 5%, 50ml | INTRAVENOUS DRIP | B05XA03 | HYPER SALINE | Hospital use only | HIGH ALERT VITAL | ||
1141 | Sodium Chloride | INJECTION, SOLUTION | 0.9%,1000ml | INTRAVENOUS DRIP | B05XA03 | NORMAL SALINE | ||||
2186 | Sodium Chloride | INJECTION, SOLUTION | 0.45%, 500ml | INTRAVENOUS DRIP | B05XA03 | HALF SALINE | Hospital use only | |||
1149 | Sodium Chloride | INJECTION, SOLUTION | 0.45%, 500ml | INTRAVENOUS DRIP | B05XA03 | HALF SALINE | Hospital use only | |||
1142 | Sodium Chloride | SOLUTION | 0.9%, 1000ml | IRRIGATION | B05CB01 | SALINE WASH | OTC medicines | |||
1143 | Sodium Chloride | SOLUTION | 0.9%, 3000ml | IRRIGATION | B05CB01 | OTC medicines | ||||
1145 | Sodium Chloride | SOLUTION | 0.9%, 500ml | IRRIGATION | B05CB01 | SALINE WASH | OTC medicines | |||
1146 | Sodium Chloride | SOLUTION/ DROPS | 0.65% | NASAL | R01AX | OTC medicines | ||||
1110 | Sodium Chloride | OINTMENT | 5% | OPHTHALMIC | S01XA03 | |||||
7259 | Sodium Chloride | SPRAY | 0.65% | NASAL | R01AX | OTC medicines | ||||
1156 | Sodium Polystyrene | Sulfonate | POWDER, FOR SUSPENSION | 454 g | ORAL | V03AE01 | ||||
14202 | Soluvit-N | POWDER, FOR INJECTION | THIAMINE 0.25 mg/RIBOFLAVIN 0.36 mg/PYRIDOXINE 0.4 mg/COBALAMIN 0.5 ug/NIACINAMIDE 4 mg/PANTOTHENIC ACID 1.5 mg/BIOTIN 6 ug/ASCORBIC ACID 10 mg/FOLIC ACID 40 ug/1mL | PARENTERAL | A11 | |||||
1162 | Sorbitol | POWDER, SACHET | 5 g | ORAL | A06AD18 | |||||
1169 | Spironolactone | TABLET | 25 mg | ORAL | C03DA01 | |||||
1173 | Streptomycin | As Sulfate | INJECTION, POWDER | 1 g | PARENTERAL | J01GA01 | Hospital use only | |||
1177 | Succinylcholine | Chloride | INJECTION, POWDER | 500 mg | PARENTERAL | M03AB01 | Hospital use only | HIGH ALERT | ||
11866 | Succinylcholine | Chloride | INJECTION | 50 mg/ml | PARENTERAL | M03AB01 | Hospital use only | |||
1180 | Sulfacetamide | Sodium | SOLUTION/ DROPS | 0.1 | OPHTHALMIC | S01AB04 | ||||
1183 | Sulfasalazine | TABLET | 500 mg | ORAL | A07EC01 | |||||
1923 | Tamsulosin | HCl | CAPSULE, EXTENDED RELEASE, PELLETS | 0.4 mg | ORAL | G04CA02 | OMNIC | |||
10488 | Teicoplanin | INJECTION, POWDER, | 400 mg | PARENTERAL | J01XA02 | TARGOCID | Hospital use only | |||
1892 | Terazosin | As HCl | TABLET | 2 mg | ORAL | G04CA03 | ||||
1202 | Tetanus Immune Globolin | INJECTION | 250 IU/ml | PARENTERAL | J06BB02 | |||||
1204 | Tetracaine | HCl | SOLUTION/ DROPS | 0.5% | OPHTHALMIC | S01AA09 | ||||
1206 | Tetracycline | HCl | OINTMENT | 1% | OPHTHALMIC | S01AA06 | ||||
1207 | Tetracycline | HCl | CAPSULE | 250 mg | ORAL | J01AA07 | ||||
1209 | Theophylline | TABLET, EXTENDED RELEASE | 200 mg | ORAL | R03DA04 | |||||
1211 | Theophylline+Guaifenesin | SOLUTION | (Theophylline anhydrous 50 mg+Guaifenesin 30 mg) / 5 ml | ORAL | R03DA54 | |||||
1219 | Thiopental | Sodium | INJECTION, POWDER | 500 mg | PARENTERAL | N01AF03 | NESDONAL | Hospital use only | HIGH ALERT | |
5635 | Tizanidine | As HCl | TABLET | 4 mg | ORAL | M03BX02 | Treatment of spasticity associated with multiple sclerosis and spinal cord injury. | |||
4578 | Tolterodine | Tartarate | TABLET | 1 mg | ORAL | G04BD07 | ||||
4579 | Tolterodine | Tartarate | TABLET | 2 mg | ORAL | G04BD07 | ||||
1885 | Topiramate | TABLET | 25 mg | ORAL | N03AX11 | Treatment of Lennox-Gastaut syndrome. | ||||
1886 | Topiramate | TABLET | 50 mg | ORAL | N03AX11 | Treatment of Lennox-Gastaut syndrome. | ||||
14111 | Trace metal | INJECTION | PARENTERAL | Pediatrace | ||||||
14113 | TRACE METAL COMBINATION (2-1) | INJECTION | CHLORIDE 0.34 mg/FERRIC CHLORIDE HEXAHYDRATE 0.54 mg/MANGANESE CHLORIDE 99 ug/POTASSIUM IODIDE 16.6 ug/SODIUM FLUORIDE 0.21 mg/SODIUM MOLYBDATE DIHYDRATE 4.85 ug/SODIUM SELENITE 6.9 ug/ZINC CHLORIDE 1.36 mg/1mL, 10 ml | PARENTERAL | V03 | ADDAMEL N | ||||
52380 | Tranexamic Acid | INJECTION | 50 mg/ml, 5ml | PARENTERAL | B02AA02 | Hospital use only | ||||
1239 | Tranexamic Acid | CAPSULE | 250 mg | ORAL | B02AA02 | |||||
1238 | Tranexamic Acid | INJECTION | 100 mg/ml, 5ml | PARENTERAL | B02AA02 | Treatment of patients undergoing prostatectomy where there is hemorrhage or risk of hemorrhage as a result of increased fibrinolysis or fibrinogenolysis. Treatment of hereditary angioneurotic edema. |
Hospital use only | |||
1242 | Trazodone | HCl | TABLET | 50 mg | ORAL | N06AX05 | ||||
1247 | Triamcinolone | Acetonide | INJECTION | 40 mg/ml | PARENTERAL | R03BA06 | ||||
1249 | Triamcinolone | Acetonide | OINTMENT | 0.1% | TOPICAL | D07AB09 | ||||
1251 | Triamcinolone NN | OINTMENT | (Triamcinolone Acetonide 1mg + Neomycin (As Sulfate) 2.5mg +Nystatin 100,000 U) / g | TOPICAL | D07BB03 | |||||
1252 | Triamterene+Hydrochlorothiazide | TABLET | Triamterene 50 mg+Hydrochlorothiazide 25 mg | ORAL | C03AX01 | |||||
1253 | Trifluoperazine | As DiHCl | TABLET | 1 mg | ORAL | N05AB06 | ||||
1267 | Tropicamide | SOLUTION/ DROPS | 0.5% | OPHTHALMIC | S01FA06 | |||||
52009 | Tropicamide | SOLUTION/ DROPS | 1% | OPHTHALMIC | S01FA06 | |||||
2497 | Ursodeoxycholic Acid | CAPSULE | 300 mg | ORAL | A05AA02 | Management of the clinical signs and symptoms associated with primary biliary cirrhosis. | ||||
10064 | Valacyclovir | As HCl | TABLET | 1000 mg | ORAL | J05AB11 | ||||
9161 | Valacyclovir | As HCl | TABLET | 500 mg | ORAL | J05AB11 | ||||
1871 | Valproate | Sodium | TABLET, EXTENDED RELEASE | 500 mg (Sodium Valproate 333mg+ Valproic Acid 145mg) | ORAL | N03AG01 | ||||
1275 | Valproate | Sodium | TABLET, DELAYED RELEASE | 200 mg | ORAL | N03AG01 | ||||
7669 | Valproate | Sodium | SYRUP | 200 mg/5ml, 125ml | ORAL | N03AG01 | ||||
8396 | Valproate | Sodium | INJECTION, POWDER | 400 mg | PARENTERAL | N03AG01 | Hospital use only | |||
5423 | Valsartan | TABLET | 80 mg | ORAL | C09CA03 | |||||
5766 | Valsartan | TABLET | 160 mg | ORAL | C09CA03 | |||||
1276 | Vancomycin | As HCl | INJECTION, POWDER | 500 mg | PARENTERAL | J01XA01 | Glycopeptide antibacterial | Hospital use only | HIGH ALERT | |
1280 | Verapamil | HCl | INJECTION | 2.5 mg/ml, 2 ml | PARENTERAL | C08DA01 | Hospital use only | HIGH ALERT VITAL | ||
1279 | Verapamil | HCl | TABLET | 40 mg | ORAL | C08DA01 | ||||
1286 | Vitamin A | OINTMENT | 250 U/g | OPHTHALMIC | S01XA02 | OTC medicines | ||||
1287 | Vitamin A | CAPSULE | 25,000 U | ORAL | A11CA01 | |||||
1288 | Vitamin A | INJECTION | 50,000 U/ml | PARENTERAL | A11CA01 | |||||
1371 | Vitamin A | CAPSULE | 50,000 U | ORAL | A11CA01 | |||||
1291 | Vitamin A+D | OINTMENT | (Vit. A 850 IU+Vit. D 85 IU) / g | TOPICAL | A11CB | OTC medicines | ||||
125 | Vitamin B Complex | INJECTION | (Vit.B1 10 mg + Vit.B2 4 mg + Vit.B6 4 mg + Dexpanthenol 6 mg + Nicotinamide 40 mg)/2ml | PARENTERAL | A11EA | |||||
1292 | Vitamin B1 | TABLET | 100 mg | ORAL | A11DA01 | OTC medicines | ||||
1293 | Vitamin B1 | TABLET | 300 mg | ORAL | A11DA01 | OTC medicines | ||||
10427 | Vitamin B1+Vitamin B6+Vitamin B12 | INJECTION | (Vit.B1 100 mg + Vit.B6 100mg + Vit.B12 1000mcg)/3ml | PARENTERAL | A11DB | NEUROBION | ||||
1294 | Vitamin B12 | INJECTION | 1000 mcg/ml | PARENTERAL | B03BA01 | Cyanocobalamin | ||||
1295 | Vitamin B6 | INJECTION | 100 mg/ml | PARENTERAL | A11HA02 | |||||
1297 | Vitamin B6 | TABLET | 40 mg | ORAL | ||||||
Vitamin C | EFFERVESENT TABLET | 1000 mg | ORAL | |||||||
Vitamin C | CHEWABLLE TABLET | 250 mg | ORAL | |||||||
1301 | Vitamin C | INJECTION | 100 mg/ml | PARENTERAL | A11GA01 | |||||
Vitamin D3 | CAPSULE LIQUID FILLED | 1000 U | ORAL | A11CC05 | OTC medicines | |||||
1814 | Vitamin D3 | INJECTION | 300,000 U | PARENTERAL | A11CC05 | |||||
1303 | Vitamin D3 | CAPSULE LIQUID FILLED | 50,000 U | ORAL | A11CC05 | OTC medicines | ||||
1003 | Vitamin K1 | INJECTION | 10 mg/ml | PARENTERAL | B02BA01 | Phytonadione | Hospital use only | |||
1004 | Vitamin K1 | INJECTION | 2 mg/ml, 0.5ml | PARENTERAL | B02BA01 | Phytonadione | Hospital use only | |||
2197 | Vitamine E | CAPSULE | 100 IU | ORAL | A11 | |||||
1309 | Warfarin | Sodium | TABLET | 5 mg | ORAL | B01AA03 | HIGH ALERT | |||
1311 | Water for Injection | INJECTION | 5 ml | PARENTERAL | V07 | WFI | ||||
Whole Blood | INJECTION | PARENTERAL | B | Blood replacement | Hospital use only | Blood and blood forming organs (INN) | ||||
Whole Blood, Irradiated | INJECTION (infusion) | PARENTERAL | B | Blood replacement | Hospital use only | Blood and blood forming organs (INN) | ||||
Whole Blood, Leucocyte Reduced | INJECTION (infusion) | PARENTERAL | B | Blood replacement | Hospital use only | Blood and blood forming organs (INN) | ||||
Whole Blood, Leucocyte Reduced and Irradiated | INJECTION (infusion) | PARENTERAL | B | Blood replacement | Hospital use only | Blood and blood forming organs (INN) | ||||
Zinc | Sulfate | SYRUPE | 10 mg/5ml, 120 ml | ORAL | ||||||
1318 | Zinc | Sulfate | Capsule | 220 mg | ORAL | B01AA04 | ||||
1316 | Zinc Oxide | OINTMENT | 25% | TOPICAL | D02AB | OTC medicines | ||||
7253 | Zolpidem | TABLET | 5 mg | ORAL | N05CF02 | |||||
6028 | Zolpidem | TABLET | 10 mg | ORAL | N05CF02 | |||||
15829 | #NAME? | CAPSULE | ORAL |